Home/Filings/4/0001453687-25-000019
4//SEC Filing

Malik Kemal 4

Accession 0001453687-25-000019

CIK 0001453687other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:19 PM ET

Size

6.8 KB

Accession

0001453687-25-000019

Insider Transaction Report

Form 4
Period: 2025-01-02
Malik Kemal
Director
Transactions
  • Award

    Common Stock

    2025-01-02+2,6008,533 total
  • Award

    Stock Option (Right to Buy)

    2025-01-02+7,8007,800 total
    Exercise: $16.93From: 2026-01-02Exp: 2035-01-01Common Stock (7,800 underlying)
Footnotes (1)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

Issuer

Cartesian Therapeutics, Inc.

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0001797921

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:19 PM ET
Size
6.8 KB